Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Russell Maxwell, MD"'
Autor:
Alicia Bao, BS, Andrew R. Barsky, MD, Stefan Both, PhD, John P. Christodouleas, MD, MPH, Curtiland Deville Jr, MD, Zelig A. Tochner, MD, Neha Vapiwala, MD, Russell Maxwell, MD
Publikováno v:
International Journal of Particle Therapy, Vol 10, Iss 1, Pp 1-12 (2023)
Purpose: Although both intensity-modulated radiation therapy (IMRT) and proton beam therapy (PBT) offer effective long-term disease control for localized prostate cancer (PCa), there are limited data directly comparing the 2 modalities. Methods: The
Externí odkaz:
https://doaj.org/article/fca313c2a893434cab18fa07dfa9e83f
Autor:
Russell Maxwell, MD, Yushi Chang, PhD, Christina Paul, CMD, David J. Vaughn, MD, John P. Christodouleas, MD, MPH
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 5, Pp 101259- (2023)
Purpose: This study's objective was to report cancer control and toxicity outcomes after proton radiation therapy (RT) in testicular seminoma and to compare secondary malignancy (SMN) risks with photon-based treatment alternatives. Methods and Materi
Externí odkaz:
https://doaj.org/article/f8ed150382f3414fb0975f59433392fc
Autor:
Jonathan A. Baron, MD, Christopher M. Wright, MD, Russell Maxwell, MD, Michele M. Kim, PhD, Fantine Giap, MD, Raymond B. Mailhot Vega, MD, MPH, Bradford S. Hoppe, MD, MPH, Michael J. LaRiviere, MD, Amit Maity, MD, PhD, John P. Plastaras, MD, PhD, Ima Paydar, MD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 1, Pp 101090- (2023)
Purpose: Combined modality therapy with multiagent chemotherapy and radiation therapy is a standard treatment option for aggressive mediastinal non-Hodgkin lymphomas (AMNHLs); however, concerns regarding acute and late radiation toxicities have fuele
Externí odkaz:
https://doaj.org/article/684c562a7fd7413887bbb92aacfaa521
Autor:
Christopher M. Wright, MD, Alexandra D. Dreyfuss, MD, MSTR, Jonathan A. Baron, BS, Russell Maxwell, MD, Amberly Mendes, BS, Andrew R. Barsky, MD, Abigail Doucette, MPH, Jakub Svoboda, MD, Elise A. Chong, MD, Joshua A. Jones, MD, Amit Maity, MD, PhD, John P. Plastaras, MD, PhD, Ima Paydar, MD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 6, Pp 101016- (2022)
Purpose: To report objective response rates (ORR), time to local failure (TTLF), and overall survival (OS) among patients with relapsed or refractory diffuse large B-cell lymphoma after salvage- or palliative-intent radiation therapy (RT) and to inve
Externí odkaz:
https://doaj.org/article/0d4438d4dcdb461fb0d9e1426019ca55
Long-term Clinical Outcomes in Favorable Risk Prostate Cancer Patients Receiving Proton Beam Therapy
Autor:
Alicia Bao, BS, Andrew R. Barsky, MD, Russell Maxwell, MD, Justin E. Bekelman, MD, Stefan Both, PhD, John P. Christodouleas, MD, MPH, Curtiland Deville, Jr, MD, Penny Fang, MD, Zelig A. Tochner, MD, Neha Vapiwala, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 4, Pp 14-24 (2021)
Purpose: Long-term data regarding the disease control outcomes of proton beam therapy (PBT) for patients with favorable risk intact prostate cancer (PC) are limited. Herein, we report our institution's long-term disease control outcomes in PC patient
Externí odkaz:
https://doaj.org/article/34367994553a4acab1273903c7300955